
The PI-RC partnership: supporting the investigator's regulatory obligations without assuming them
Addresses the most consequential relationship in the RC's professional life: navigating the line between supporting and assuming the investigator's regulatory responsibilities.
The name on the 1572
The principal investigator's name appears on the FDA Form 1572. Their medical license underwrites the trial's conduct. Their signature on the protocol agreement constitutes a personal commitment -- to the sponsor, to the IRB, to the regulatory authority -- that this trial will be conducted in compliance with GCP and applicable regulations. When a regulatory authority inspects the site, it is the investigator they hold accountable. Not the coordinator. Not the institution. The investigator.